|
1
|
Mitochondria, calcium, and calpain are key mediators of resveratrol-induced apoptosis in breast cancer.
|
Mol Pharmacol
|
2007
|
1.35
|
|
2
|
Expression of the receptor tyrosine kinase Axl promotes ocular melanoma cell survival.
|
Cancer Res
|
2004
|
1.32
|
|
3
|
Resveratrol inhibits tumor growth of human neuroblastoma and mediates apoptosis by directly targeting mitochondria.
|
Clin Cancer Res
|
2007
|
1.21
|
|
4
|
Mitochondria as the primary target of resveratrol-induced apoptosis in human retinoblastoma cells.
|
Invest Ophthalmol Vis Sci
|
2006
|
1.08
|
|
5
|
Resveratrol inhibits uveal melanoma tumor growth via early mitochondrial dysfunction.
|
Invest Ophthalmol Vis Sci
|
2008
|
0.99
|
|
6
|
Resveratrol: challenges in translation to the clinic--a critical discussion.
|
Clin Cancer Res
|
2010
|
0.97
|
|
7
|
The anti-tumor effect of resveratrol alone or in combination with immunotherapy in a neuroblastoma model.
|
Cancer Immunol Immunother
|
2011
|
0.87
|
|
8
|
Expression of angiogenic factors Cyr61 and tissue factor in uveal melanoma.
|
Arch Ophthalmol
|
2002
|
0.87
|
|
9
|
Ca2+ binding to EF hands 1 and 3 is essential for the interaction of apoptosis-linked gene-2 with Alix/AIP1 in ocular melanoma.
|
Biochemistry
|
2004
|
0.85
|
|
10
|
Resveratrol metabolites do not elicit early pro-apoptotic mechanisms in neuroblastoma cells.
|
J Agric Food Chem
|
2011
|
0.84
|
|
11
|
Resveratrol modulates the malignant properties of cutaneous melanoma through changes in the activation and attenuation of the antiapoptotic protooncogenic protein Akt/PKB.
|
Melanoma Res
|
2011
|
0.82
|
|
12
|
Cancer-related diseases of the eye: the role of calcium and calcium-binding proteins.
|
Biochem Biophys Res Commun
|
2004
|
0.79
|
|
13
|
A synergetic screening approach with companion effector for combination therapy: application to retinoblastoma.
|
PLoS One
|
2013
|
0.78
|
|
14
|
Anti-tumor and immunomodulatory activity of resveratrol in vitro and its potential for combining with cancer immunotherapy.
|
Int Immunopharmacol
|
2011
|
0.76
|
|
15
|
Introducing Krzysztof Palczewski, the 2014 recipient of the Friedenwald award.
|
Invest Ophthalmol Vis Sci
|
2014
|
0.75
|